Muscone exerts neuroprotection in an experimental model of stroke via inhibition of the fas pathway

Natural Product Communications

Volumn 7, Issue 8, 2012, Pages 1069-1074

  Wei, Gang ^a   Chen, Dong Feng ^a   Lai, Xiao Ping ^a   Liu, Dong Hui ^a   Deng, Ru Dong ^a   Zhou, Jian Hong ^a   Zhang, Sai Xia ^a   Li, Yi Wei ^a   Li, Hui ^a   Zhang, Qiong Dan ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cerebral ischemia; Fas death pathway; Muscone; Neuronal apoptosis; Small molecules

Indexed keywords

CASPASE 8; CHINESE DRUG; FAS ANTIGEN; GLUTAMIC ACID; MUSCONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG; XINGNAOJING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN DYSFUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL STRAIN; CELL VIABILITY; CHINESE MEDICINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; GAS CHROMATOGRAPHY; INHIBITION KINETICS; MALE; MASS SPECTROMETRY; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION;

EID: 84865300682     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1200700826     Document Type: Article

References (41)

1. Mathers CD, Loncar D. (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3, 2011-2029.
2. Lipton P. (1999) Ischemic cell death in brain neurons. Physiological Reviews, 79, 1431-1568.
3. Chan PH. (2001) Reactive oxygen radicals in signaling and damage in the ischemic brain. Journal of Cerebral Blood Flow & Metabolism, 21, 2-14.
4. Graham SH, Chen J. (2001) Programmed cell death in cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism, 21, 99-109.
5. Ginsberg MD. (2008) Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology, 55, 363-389.
6. Wei N, Ma C, Duan T. (2005) Determination of muscone in Xingnaojing injection by gas chromatography with solid phase microextraction. Se. Pu, 23, 565.
7. Wu B, Liu M, Liu H, Li W, Tan S. (2007) Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke, 38, 1973-1979.
8. Shen SY, Cai DF, Chen WH, Liu J, Chen H, Ying J. (2003) Effect of XingnaoJing injection on hippocampal N-methyl-D-aspartic acid (NMDA) receptors of focal cerebral ischemia in rats. Chinese Journal of Integrative Medicine, 9, 49-52.
9. Chen WK, Huang YF, Wang H. (2004) An experimental study on distribution of musk into the brain through blood brain barrier. Journal of Chinese Integrative Medicine, 2, 288-291.
10. Sun R, Zhang Z, Huang W, Lv L, Yin J. (2009) Protective effects and mechanism of muskone on pheochromocytoma cell injure induced by glutamate. China Journal of Chinese Materia Medica, 34, 1701-1704.
11. Rosenbaum DM, Gupta G, D'Amore J, Singh M, Weidenheim K, Zhang H, Kessler JA. (2000) Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. Journal of Neuroscience Research, 61, 686-692.
12. Padosch SA, Popp E, Vogel P, Bottiger BW. (2003) Altered protein expression levels of Fas/CD95 and Fas ligand in differentially vulnerable brain areas in rats after global cerebral ischemia. Neuroscience Letters, 338, 247-251.
13. Liu L, Kim JY, Koike MA, Yoon YJ, Tang XN, Ma H, Lee H, Steinberg GK, Lee JE, Yenari MA. (2008) FasL shedding is reduced by hypothermia in experimental stroke. Journal of Neurochemistry, 106, 541-550.
14. Ruan W, Lee CT, Desbarats J. (2008) A novel juxtamembrane domain in tumor necrosis factor receptor superfamily molecules activates rac1 and controls neurite growth. Molecular Biology of the Cell, 19, 3192-3202.
15. Nagata S, Golstein P. (1995) The Fas death factor. Science, 267, 1449-1456.
16. Qiu J, Whalen MJ, Lowenstein P, Fiskum G, Fahy B, Darwish R, Aarabi B, Yuan J, Moskowitz MA. (2002) Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. The Journal of Neuroscience, 22, 3504-3511.
17. Lee KH, Feig C, Tchikov V, Schickel R, Chan AC. (2006) The role of receptor internalization in CD95 signaling. The EMBO Journal, 25, 1009-23.
18. Ashkenaz A, Dixit VM. (1998) Death receptors: signaling and modulation. Science, 281, 1305-1308.
19. Nagata S. (1999) Fas ligand-induced apoptosis. Annual Review of Genetics, 33, 29-55.
20. Blankenberg FG, Kalinyak J, Liu L, Koike M, Cheng D, Goris ML, Green A, Vanderheyden JL, Tong DC, Yenari MA. (2006) 99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody. European Journal of Nuclear Medicine and Molecular Imaging, 33, 566-574.
21. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Debatin KM. (1999) CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. Journal of Neuroscience, 19, 3809-3817.
22. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH. (2001) Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death & Differentiation, 8, 679-686.
23. Solaroglu I, Tsubokawa T, Cahill J, Zhang JH. (2006) Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Journal of Neuroscience, 143, 965-974.
24. Sairanen T, Karjalainen-Lindsberg ML, Paetau A, Ijas P, Lindsberg PJ. (2006) Apoptosis dominant in the peri-infarct area of human ischaemic stroke: a possible target of antiapoptotic treatments. Brain, 129, 189-199.
25. Kogo J, Takeba Y, Kumai T, Kitaoka Y, Matsumoto N, Ueno S, Kobayashi S. (2006) Involvement of TNF-alpha in glutamate-induced apoptosis in a differentiated neuronal cell line. Brain Research, 1, 201-208.
26. Schurr A. (2004) Neuroprotection against ischemic/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels. Current Drug Targets, 5, 603-618.
27. Aliprandi A, Longoni M, Stanzani L, Tremolizzo L, Vaccaro M, Begni B, Galimberti G, Rosanna G, Ferrarese C. (2005) Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake. Journal of Cerebral Blood Flow & Metabolism, 25, 513-519.
28. Le DA, Wu Y, Huang Z, Matsushita K, Plesnila N, Augustinack JC, Hyman BT, Yuan J, Kuida K, Flavell RA, Moskowitz MA. (2002) Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proceedings of the National Academy of Sciences of the United States of America, 99, 15188-15193.
29. Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gomez-Isla T, Hyman BT, Moskowitz MA. (1998) Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. Journal of Cerebral Blood Flow & Metabolism, 18, 238-247.
30. Ma J, Endres M, Moskowitz MA. (1998) Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice. British Journal of Pharmacology, 124, 756-762.
31. Mouw G, Zechel JL, Zhou Y, Lust WD, Selman WR, Ratcheson RA. (2002) Caspase-9 inhibition after focal cerebral ischemia improves outcome following reversible focal ischemia. Metabolic Brain Disease, 17, 143-151.
32. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, Dawson VL. (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Medicine, 3, 1089-1095.
33. Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA. (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. Journal of Cerebral Blood Flow & Metabolism, 17, 1143-1151.
34. Nagata S. (1997) Apoptosis by death factor. Cell, 88, 355-365.
35. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper O C, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P, Wallach D. (1998) Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity, 9, 267-276.
36. Ackery A, Robins S, Fehlings MG. (2006) Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. Journal of Neurotrauma, 23, 604-616.
37. Chen HL, Lein PJ, Wang JY, Gash D, Hoffer BJ, Chiang YH. (2003) Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals. Brain Research, 994, 81-90.
38. Tatton WG, Chalmers-Redman RME, Ju WJH, Mammen M, Carlile GW, Pong AW, Tatton NA. (2002) Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. Journal of Pharmacology and Experimental Therapeutics, 301, 753-764.
39. Xu Y, Traystman RJ, Hurn PD, Wang MM. (2003) Neurite-localized estrogen receptor-alpha mediates rapid signaling by estrogen. Journal of Neuroscience Research, 74, 1-11.
40. Longa EZ, Weinstein PR, Cummins R. (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20, 84-91.
41. Garcia JH, Wagner S, Liu KF, Hu XJ. (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke, 26, 627-634.